title: Disseminated necrotizing leukoencephalopathy eight months after alemtuzumab treatment for multiple sclerosis.
authors: Department of Neuropathology, University Medical Center Göttingen, Georg-August-University, Robert-Koch-Str. 40, 37075, Göttingen, Germany. imetz@gwdg.de.
authors: Imke
authors: 0000-0002-6571-7630
authors: I
authors: Metz
authors: Department of Neurology, Sozialstiftung Bamberg Hospital, Buger Str. 80, 96049, Bamberg, Germany.
authors: Peter
authors: P
authors: Rieckmann
authors: Neurological Practice Kallmann, Kärntenstr. 2, 96052, Bamberg, Germany.
authors: Boris-Alexander
authors: BA
authors: Kallmann
authors: Department of Neuropathology, University Medical Center Göttingen, Georg-August-University, Robert-Koch-Str. 40, 37075, Göttingen, Germany.
authors: Wolfgang
authors: W
authors: Brück
mesh_terms: D000328:Adult; D000074323:Alemtuzumab / Q000009:adverse effects* / Q000627:therapeutic use; D001921:Brain / Q000187:drug effects / Q000473:pathology; D017809:Fatal Outcome; D005260:Female; D006801:Humans; D007155:Immunologic Factors / Q000009:adverse effects* / Q000627:therapeutic use; D056784:Leukoencephalopathies / Q000150:complications* / Q000473:pathology; D020529:Multiple Sclerosis, Relapsing-Remitting / Q000188:drug therapy* / Q000473:pathology
chemical_list: D007155:Immunologic Factors; D000074323:Alemtuzumab